Oxaloacetate metabolic process

pathway activity — cross-omics
GO:0006107Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Oxaloacetate metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RPS29, KRT8P9, and PITHD1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Oxaloacetate metabolic process activity versus RPS29 in LUAD (Pearson r = -0.29).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADRPS29 →-0.393-0.107.008<.00134
BRCAKRT8P9 →-0.640-0.144.006.00834
BRCAPITHD1 →-0.399-0.191<.001<.00134
CCRCCPROC →+0.996+0.167<.001<.00133
CCRCCPOF1B →+1.493+0.156.002<.00133
CCRCCMAGED4B →-0.011-0.116.004.00433
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006107 vs RPS29 — LUAD

Per-sample scatter of Oxaloacetate metabolic process activity vs RPS29 in LUAD.

Explore this scatter interactively →

Exploration